|
1
|
Moulis F, Durrieu G and Lapeyre-Mestre M:
Off-label and unlicensed drug use in children population. Therapie.
73:135–149. 2018.PubMed/NCBI View Article : Google Scholar
|
|
2
|
van Riet-Nales DA, Schobben AF, Egberts TC
and Rademaker CM: Effects of the pharmaceutical technologic aspects
of oral pediatric drugs on patient-related outcomes: A systematic
literature review. Clin Ther. 32:924–938. 2010.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chen J, Luo X, Qiu H, Mackey V, Sun L and
Ouyang X: Drug discovery and drug marketing with the critical roles
of modern administration. Am J Transl Res. 10:4302–4312.
2018.PubMed/NCBI
|
|
4
|
Thompson G, Barker CI, Folgori L, Bielicki
JA, Bradley JS, Lutsar I and Sharland M: Global shortage of
neonatal and paediatric antibiotic trials: Rapid review. BMJ Open.
7(e016293)2017.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Joseph PD, Craig JC and Caldwell PHY:
Clinical trials in children. Br J Clin Pharmacol. 79:357–369.
2015.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Gore R, Chugh PK, Tripathi CD, Lhamo Y and
Gautam S: Pediatric off-label and unlicensed drug use and its
implications. Curr Clin Pharmacol. 12:18–25. 2017.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Paine MF: Therapeutic disasters that
hastened safety testing of new drugs. Clin Pharmacol Ther.
101:430–434. 2017.PubMed/NCBI View
Article : Google Scholar
|
|
8
|
Leandro JA: ‘Risk-free rest and sleep:’
Jornal do Médico (Portugal) and the thalidomide disaster,
1960-1962. Hist Cienc Saude Manguinhos. 27:15–32. 2020.PubMed/NCBI View Article : Google Scholar : (In Portuguese,
English).
|
|
9
|
Nir-Neuman H, Abu-Kishk I, Toledano M,
Heyman E, Ziv-Baran T and Berkovitch M: Unlicensed and off-label
medication use in pediatric and neonatal intensive care units: No
change over a decade. Adv Ther. 35:1122–1132. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Landwehr C, Richardson J, Bint L, Parsons
R, Sunderland B and Czarniak P: Cross-sectional survey of off-label
and unlicensed prescribing for inpatients at a paediatric teaching
hospital in Western Australia. PLoS One.
14(e0210237)2019.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Kleeblatt J, Betzler F, Kilarski LL,
Bschor T and Köhler S: Efficacy of off-label augmentation in
unipolar depression: A systematic review of the evidence. Eur
Neuropsychopharmacol. 27:423–441. 2017.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Shaikh M and Gandjour A: Pharmaceutical
expenditure and gross domestic product: Evidence of simultaneous
effects using a two-step instrumental variables strategy. Health
Econ. 28:101–122. 2019.PubMed/NCBI View
Article : Google Scholar
|
|
13
|
Mori AT, Meena E and Kaale EA: Economic
cost of substandard and falsified human medicines and cosmetics
with banned ingredients in Tanzania from 2005 to 2015: A
retrospective review of data from the regulatory authority. BMJ
Open. 8(e021825)2018.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moreira M and Sarraguça M: How can oral
paediatric formulations be improved? A challenge for the XXI
century. Int J Pharm. 590(119905)2020.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Leucht S, Corves C, Arbter D, Engel RR, Li
C and Davis JM: Second-generation versus first-generation
antipsychotic drugs for schizophrenia: A meta-analysis. Lancet.
373:31–41. 2009.PubMed/NCBI View Article : Google Scholar
|
|
16
|
International Monetary Fund: Real GDP
growth. [Internet]. International Monetary Fund, Geneva, 2020.
https://www.imf.org/external/datamapper/NGDP_RPCH@WEO/OEMDC/ADVEC/WEOWORLD.
Accessed August 7, 2020.
|
|
17
|
Page MJ, McKenzie JE, Bossuyt PM, Boutron
I, Hoffmann TC, Mulrow CD, Shamseer L, Tetzlaff JM, Akl EA, Brennan
SE, et al: The PRISMA 2020 statement: An updated guideline for
reporting systematic reviews. BMJ. 372(n71)2021.PubMed/NCBI View
Article : Google Scholar
|
|
18
|
Barker TH, Stone JC, Sears K, Klugar M,
Tufanaru C, Leonardi-Bee J, Aromataris E and Munn Z: The revised
JBI critical appraisal tool for the assessment of risk of bias for
randomized controlled trials. JBI Evid Synth. 21:494–506.
2023.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Turner S, Nunn AJ, Fielding K and Choonara
I: Adverse drug reactions to unlicensed and off-label drugs on
paediatric wards: A prospective study. Acta Paediatr. 88:965–968.
1999.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Conroy S, McIntyre J and Choonara I:
Unlicensed and off label drug use in neonates. Arch Dis Child Fetal
Neonatal Ed. 80:F142–F144. 1999.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Pandofini C, Impicciatore P, Provasi D,
Rocchi F, Campi R and Bonati M: Italian Paediatric Off-label
Collaborative Group. Off-label use of drugs in Italy: A
prospective, observational and multicentre study. Acta Paediatr.
91:339–347. 2002.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Barr J, Brenner-Zada G, Heiman E, Pareth
G, Bulkowstein M, Greenberg R and Berkovitch M: Unlicensed and
off-label medication use in a neonatal intensive care unit: A
prospective study. Am J Perinatol. 19:67–72. 2002.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Jong GW, van der Linden PD, Bakker EM, van
der Lely N, Eland IA, Stricker BH and van den Anker JN: Unlicensed
and off-label drug use in a paediatric ward of a general hospital
in the Netherlands. Eur J Clin Pharmacol. 58:293–297.
2002.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Conroy S, Newman C and Gudka S: Unlicensed
and off label drug use in acute lymphoblastic leukaemia and other
malignancies in children. Ann Oncol. 14:42–47. 2003.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Jong GW, Eland IA, Sturkenboom MC, van den
Anker JN and Strickerf BH: Unlicensed and off-label prescription of
respiratory drugs to children. Eur Respir J. 23:310–313.
2004.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Neubert A, Dormann H, Weiss J, Egger T,
Criegee-Rieck M, Rascher W, Brune K and Hinz B: The impact of
unlicensed and off-label drug use on adverse drug reactions in
paediatric patients. Drug Saf. 27:1059–1067. 2004.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Bajcetic M, Jelisavcic M, Mitrovic J,
Divac N, Simeunovic S, Samardzic R and Gorodischer R: Off label and
unlicensed drugs use in paediatric cardiology. Eur J Clin
Pharmacol. 61:775–779. 2005.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Di Paolo ER, Stoetter H, Cotting J, Frey
P, Gehri M, Beck-Popovic M, Tolsa JF, Fanconi S and Pannatier A:
Unlicensed and off-label drug use in a Swiss paediatric university
hospital. Swiss Med Wkly. 136:218–222. 2006.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kaisi T, Maponga CC, Gavaza P and
Pazvakavambwa IE: An assessment of the extent of use of off-license
and unlicensed drugs on children at Parirenyatwa Hospital in
Harare, Zimbabwe. East Cent Afr J Pharm Sci. 9:3–7. 2007.
|
|
30
|
Santos DB, Clavenna A, Bonati M and Coelho
HL: Off-label and unlicensed drug utilization in hospitalized
children in Fortaleza, Brazil. Eur J Clin Pharmacol. 64:1111–1118.
2008.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Bavdekar SB, Sadawarte PA, Gogtay NJ, Jain
SS and Jadhav S: Off-label drug use in a pediatric intensive care
unit. Indian J Pediatr. 76:1113–1118. 2009.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Lass J, Käär R, Jõgi K, Varendi H,
Metsvaht T and Lutsar I: Drug utilisation pattern and off-label use
of medicines in Estonian neonatal units. Eur J Clin Pharmacol.
67:1263–1271. 2011.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Palčevski G, Skočibušić N and
Vlahović-Palčevski V: Unlicensed and off-label drug use in
hospitalized children in Croatia: A cross-sectional survey. Eur J
Clin Pharmacol. 68:1073–1077. 2012.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Oguz SS, Kanmaz HG and Dilmen U: Off-label
and unlicensed drug use in neonatal intensive care units in Turkey:
The old-inn study. Int J Clin Pharm. 34:136–141. 2012.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Ballard CD, Peterson GM, Thompson AJ and
Beggs SA: Off-label use of medicines in paediatric inpatients at an
Australian teaching hospital. J Paediatr Child Health. 49:38–42.
2013.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Kieran EA, O'Callaghan N and O'Donnell CP:
Unlicensed and off-label drug use in an Irish neonatal intensive
care unit: A prospective cohort study. Acta Paediatr.
103:e139–e142. 2014.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Silva J, Flor-de-Lima F, Soares H and
Guimarães H: Off-label and unlicensed drug use in neonatology:
Reality in a Portuguese University Hospital. Acta Med Port.
28:297–306. 2015.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lee JL, Redzuan AM and Shah NM: Unlicensed
and off-label use of medicines in children admitted to the
intensive care units of a hospital in Malaysia. Int J Clin Pharm.
35:1025–1029. 2013.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ribeiro M, Jorge A and Macedo AF:
Off-label drug prescribing in a Portuguese paediatric emergency
unit. Int J Clin Pharm. 35:30–36. 2013.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Lindell-Osuagwu L, Hakkarainen M, Sepponen
K, Vainio K, Naaranlahti T and Kokki H: Prescribing for off-label
use and unauthorized medicines in three paediatric wards in
Finland, the status before and after the European Union Paediatric
regulation. J Clin Pharm Ther. 39:144–153. 2014.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Laforgia N, Nuccio MM, Schettini F,
Dell'Aera M, Gasbarro AR, Dell'Erba A and Solarino B: Off-label and
unlicensed drug use among neonatal intensive care units in Southern
Italy. Pediatr Int. 56:57–59. 2014.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Langerová P, Vrtal J and Urbánek K:
Incidence of unlicensed and off-label prescription in children.
Ital J Pediatr. 40(12)2014.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Luedtke KE and Buck ML: Evaluation of
off-label prescribing at a children's rehabilitation center. J
Pediatr Pharmacol Ther. 19:296–301. 2014.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Riou S, Plaisant F, Boulch DM, Kassai B,
Claris O and Nguyen KA: Unlicensed and off-label drug use: A
prospective study in French NICU. Acta Paediatr. 104:e228–e231.
2015.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Joret-Descout P, Prot-Labarthe S, Brion F,
Bataille J, Hartmann JF and Bourdon O: Off-label and unlicensed
utilisation of medicines in a French paediatric hospital. Int J
Clin Pharm. 37:1222–1227. 2015.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Jobanputra N, Save SU and Bavdekar SB:
Off-label and unlicensed drug use in children admitted to pediatric
intensive care units (PICU). Int J Risk Saf Med. 27:113–121.
2015.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Berdkan S, Rabbaa L, Hajj A, Eid B,
Jabbour H, El Osta NE, Karam L and Khabbaz LR: Comparative
assessment of off-label and unlicensed drug prescriptions in
children: FDA versus ANSM guidelines. Clin Ther. 38:1833–1844.
2016.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Cuzzolin L and Agostino R: Off-label and
unlicensed drug treatments in neonatal intensive care units: An
Italian multicentre study. Eur J Clin Pharmacol. 72:117–123.
2016.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Corny J, Bailey B, Lebel D and Bussières
JF: Unlicensed and off-label drug use in paediatrics in a
mother-child tertiary care hospital. Paediatr Child Health.
21:83–87. 2016.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Ramadaniati HU, Tambunan T, Khairani S and
Adisty HS: Off-label and unlicensed prescribing in pediatric
inpatients with nephrotic syndrome in a major teaching hospital: An
Indonesian context. Asian J Pharm Clin Res. 10:355–359. 2017.
|
|
51
|
Tefera YG, Gebresillassie BM, Mekuria AB,
Abebe TB, Erku DA, Seid N and Beshir HB: Off-label drug use in
hospitalized children: A prospective observational study at Gondar
University Referral Hospital, Northwestern Ethiopia. Pharmacol Res
Perspect. 5(e00304)2017.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Teigen A, Wang S, Truong BT and Bjerknes
K: Off-label and unlicensed medicines to hospitalised children in
Norway. J Pharm Pharmacol. 69:432–438. 2017.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Costa HTML, Costa TX, Martins RR and
Oliveira AG: Use of off-label and unlicensed medicines in neonatal
intensive care. PLoS One. 13(e0204427)2018.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Mazhar F, Akram S, Haider N, Hadi MA and
Sultana J: Off-label and unlicensed drug use in hospitalized
newborns in a Saudi tertiary care hospital: A cohort study. Int J
Clin Pharm. 40:700–703. 2018.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Aamir M, Khan JA, Shakeel F, Shareef R and
Shah N: Drug utilization in neonatal setting of Pakistan: Focus on
unlicensed and off label drug prescribing. BMC Pediatr.
18(242)2018.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Dornelles AD, Calegari LH, de Souza L,
Ebone P, Tonelli TS and Carvalho CG: The unlicensed and off-label
prescription of medications in general paediatric ward: An
observational study. Curr Pediatr Rev. 15:62–66. 2019.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Kouti L, Aletayeb M, Aletayeb SMH, Hardani
AK and Eslami K: Pattern and extent of off-label and unlicensed
drug use in neonatal intensive care units in Iran. BMC Pediatr.
19(3)2019.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Tukayo BLA, Sunderland B, Parsons R and
Czarniak P: High prevalence of off-label and unlicensed paediatric
prescribing in a hospital in Indonesia during the period Aug.-Oct.
2014. PLoS One. 15(e0227687)2020.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Gidey MT, Gebretsadkan YG, Tsadik AG,
Welie AG and Assefa BT: Off-label and unlicensed drug use in Ayder
comprehensive specialized hospital neonatal intensive care unit.
Ital J Pediatr. 46(41)2020.PubMed/NCBI View Article : Google Scholar
|
|
60
|
García-López I, Vendrell MCM, Romero IM,
de Noriega I, González JB and Martino-Alba R: Off-label and
unlicensed drugs in pediatric palliative care: A prospective
observational study. J Pain Symptom Manage. 60:923–932.
2020.PubMed/NCBI View Article : Google Scholar
|
|
61
|
AlAzmi A, Alasmari Z, Yousef C, Alenazi A,
AlOtaibi M, AlSaedi H, AlShaikh A, AlObathani A, Ahmed O,
Goronfolah L and Alahmari M: Off-Label drug use in pediatric
out-patient care: A multi-center observational study. Hosp Pharm.
56:690–696. 2021.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Tsukamoto K, Carroll KA, Onishi T,
Matsumaru N, Brasseur D and Nakamura H: Improvement of pediatric
drug development: Regulatory and practical frameworks. Clin Ther.
38:574–581. 2016.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Shakeel S, Iffat W, Nesar S, Zaidi H and
Jamshed S: Exploratory findings of prescribing unlicensed and
off-label medicines among children and neonates. Integr Pharm Res
Pract. 9:33–39. 2020.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Andrade SRA, Santos PANM, Andrade PHS and
da Silva WB: Unlicensed and off-label prescription of drugs to
children in primary health care: A systematic review. J Evid Based
Med. 13:292–300. 2020.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Turner S, Gill A, Nunn T, Hewitt B and
Choonara I: Use of ‘off-label’ and unlicensed drugs in paediatric
intensive care unit. Lancet. 347:549–550. 1996.PubMed/NCBI
|
